Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Sales (2016 - 2025)

Collegium Pharmaceutical has reported Return on Sales over the past 10 years, most recently at 0.08% for Q4 2025.

  • Quarterly results put Return on Sales at 0.08% for Q4 2025, up 1.0% from a year ago — trailing twelve months through Dec 2025 was 0.08% (down 6.0% YoY), and the annual figure for FY2025 was 0.08%, down 3.0%.
  • Return on Sales for Q4 2025 was 0.08% at Collegium Pharmaceutical, down from 0.15% in the prior quarter.
  • Over the last five years, Return on Sales for COLL hit a ceiling of 1.17% in Q3 2024 and a floor of 3.6% in Q1 2022.
  • Median Return on Sales over the past 5 years was 0.09% (2023), compared with a mean of 0.05%.
  • Biggest five-year swings in Return on Sales: plummeted -377bps in 2022 and later surged 347bps in 2023.
  • Collegium Pharmaceutical's Return on Sales stood at 0.65% in 2021, then surged by 91bps to 0.06% in 2022, then skyrocketed by 484bps to 0.21% in 2023, then tumbled by -68bps to 0.07% in 2024, then increased by 20bps to 0.08% in 2025.
  • The last three reported values for Return on Sales were 0.08% (Q4 2025), 0.15% (Q3 2025), and 0.06% (Q2 2025) per Business Quant data.